Comparison of remimazolam and propofol anesthesia for interventional neuroradiology

Comparison of remimazolam and propofol anesthesia for interventional neuroradiology - Remimazolam anesthesia for interventional neuroradiology

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047384

Enrollment

Registered

2022-04-04

Start date

2022-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IV general anesthesia for interventional neuroradiology

Interventions

In the intervention group, general anesthesia is performed using intravenous remimazolam infusion. In the intervention group, general anesthesia is performed using intravenous propofol infusion.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - ASA I-III - Unruptured intracranial aneurysm - Coiling procedures

Exclusion criteria

Exclusion criteria: - A ruptured aneurysm - Multiple aneurysms - History of neuromuscular/cognitive/psychiatric disease (on medication) - Preexisting renal or hepatic dysfunction - Glaucoma

Design outcomes

Primary

Measure	Time frame
- Total phenylephrine dose required to restore blood pressure during hypotensive events during the procedure	—

Secondary

Measure	Time frame
- The number of hypotension events - Intraoperative remifentanil dose - Time from the end of hemostatic compression to return of spontaneous breathing, time to eye opening, time to extubation, and time to orientation recovery - Time from the end of hemostatic compression to BIS 75, time from flumazenil injection to extubation, time from flumazenil injection to return of orientation (only in remimazolam group) - Intraoperative vital signs	—

Measure

Time frame

- The number of hypotension events - Intraoperative remifentanil dose - Time from the end of hemostatic compression to return of spontaneous breathing, time to eye opening, time to extubation, and time to orientation recovery - Time from the end of hemostatic compression to BIS 75, time from flumazenil injection to extubation, time from flumazenil injection to return of orientation (only in remimazolam group) - Intraoperative vital signs

—

Countries

Asia(except Japan)

Contacts

Public ContactJin-Woo Park

Seoul National University Bundang Hospital Department of Anesthesiology and Pain Medicine

jinul8282@gmail.com82-31-787-7499

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026